November 5, 2012

The Food and Drug Administration has approved a generic drug for treating blood pressure and chest pain.

October 22, 2012

Watson Pharmaceuticals and Actavis will have to divest rights to almost two dozen drugs as a condition for U.S. regulatory approval of their $5.6 billion merger announced earlier this year, according to regulatory documents.